Solid lipid nanoparticles as nucleic acid delivery system: Properties and molecular mechanisms

Journal of Controlled Release

Volumn 201, Issue , 2015, Pages 1-13

  De Jesus, Marcelo B ^a,b   Zuhorn, Inge S ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Gene delivery; Solid lipid nanoparticles

Indexed keywords

BIOMOLECULES; DRUG DELIVERY; GENE TRANSFER; GENES; NANOPARTICLES;

DRUG DELIVERY SYSTEM; GENE DELIVERY; GENE DELIVERY SYSTEMS; NUCLEIC ACID DELIVERIES; PHARMACEUTICAL APPLICATIONS; SOLID LIPID NANOPARTICLE (SLN); SOLID LIPID NANOPARTICLES; STRUCTURE-FUNCTION RELATIONSHIP;

NUCLEIC ACIDS;

NUCLEIC ACID; SOLID LIPID NANOPARTICLE; LIPID; NANOPARTICLE;

DRUG DELIVERY SYSTEM; DRUG MECHANISM; FREEZE DRYING; GENE DELIVERY SYSTEM; GENE TARGETING; HUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; SUSTAINED DRUG RELEASE; ANIMAL; CHEMISTRY; DRUG STABILITY; GENE TRANSFER;

ANIMALS; DRUG STABILITY; FREEZE DRYING; GENE TRANSFER TECHNIQUES; HUMANS; LIPIDS; NANOPARTICLES; NUCLEIC ACIDS;

EID: 84921059282     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.01.010     Document Type: Review

References (153)

1. C. Sheridan Gene therapy finds its niche Nat. Biotechnol. 29 2011 121 128 10.1038/nbt.1769
2. C.M. Wiethoff, and C.R. Middaugh Barriers to nonviral gene delivery J. Pharm. Sci. 92 2003 203 217 10.1002/jps.10286
3. I.S. Zuhorn, J.B.F.N. Engberts, and D. Hoekstra Gene delivery by cationic lipid vectors: overcoming cellular barriers Eur. Biophys. J. 36 2007 349 362 10.1007/s00249-006-0092-4
4. F.C. Pérez-Martínez, J. Guerra, I. Posadas, and V. Ceña Barriers to non-viral vector-mediated gene delivery in the nervous system Pharm. Res. 28 2011 1843 1858 10.1007/s11095-010-0364-7
5. C.S. Manno, G.F. Pierce, V.R. Arruda, B. Glader, M. Ragni, and J.J. Rasko Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response Nat. Med. 12 2006 342 347 10.1038/nm1358
6. F. Mingozzi, J.J. Meulenberg, D.J. Hui, E. Basner-Tschakarjan, N.C. Hasbrouck, and S.A. Edmonson AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells Blood 114 2009 2077 2086 10.1182/blood-2008-07-167510
7. M. Sadelain, E.P. Papapetrou, and F.D. Bushman Safe harbours for the integration of new DNA in the human genome Nat. Rev. Cancer 12 2012 51 58 10.1038/nrc3179
8. A. Pathak, S. Patnaik, and K.C. Gupta Recent trends in non-viral vector-mediated gene delivery Biotechnol. J. 4 2009 1559 1572 10.1002/biot.200900161
9. J. Wei, J. Jones, J. Kang, A. Card, M. Krimm, and P. Hancock RNA-induced silencing complex-bound small interfering RNA is a determinant of RNA interference-mediated gene silencing in mice Mol. Pharmacol. 79 2011 953 963 10.1124/mol.110.070409
10. T.T. Lobovkina, G.B.G. Jacobson, E.E. Gonzalez-Gonzalez, R.P.R. Hickerson, D.D. Leake, and R.L.R. Kaspar In vivo sustained release of siRNA from solid lipid nanoparticles ACS Nano 5 2011 9977 9983 10.1021/nn203745n
11. R. Goyal, S.K. Tripathi, S. Tyagi, K. Ravi Ram, K.M. Ansari, and Y. Shukla Gellan gum blended PEI nanocomposites as gene delivery agents: evidences from in vitro and in vivo studies Eur. J. Pharm. Biopharm. 79 2011 3 14 10.1016/j.ejpb.2011.01.009
12. G. McLachlan, H. Davidson, E. Holder, L.A. Davies, I.A. Pringle, and S.G. Sumner-Jones Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung Gene Ther. 18 2011 996 1005 10.1038/gt.2011.55
13. S.L. Ginn, I.E. Alexander, M.L. Edelstein, M.R. Abedi, and J. Wixon Gene therapy clinical trials worldwide to 2012 - an update J. Gene Med. 15 2013 65 77 10.1002/jgm.2698
14. Z.U. Rehman, I.S. Zuhorn, and D. Hoekstra How cationic lipids transfer nucleic acids into cells and across cellular membranes: recent advances J. Control. Release 166 2013 46 56 10.1016/j.jconrel.2012.12.014
15. M.J. Hope Enhancing siRNA delivery by employing lipid nanoparticles Ther. Deliv. 5 2014 663 673 10.4155/tde.14.37
16. J.R. Viola, S. El Andaloussi, I.I. Oprea, and C.I.E. Smith Non-viral nanovectors for gene delivery: factors that govern successful therapeutics Expert Opin. Drug Deliv. 7 2010 721 735 10.1517/17425241003716810
17. X. Guo, and L. Huang Recent advances in nonviral vectors for gene delivery Acc. Chem. Res. 45 2012 971 979 10.1021/ar200151m
18. H. Cui, Y. Feng, W. Ren, T. Zeng, H. Lv, and Y. Pan Strategies of large scale synthesis of monodisperse nanoparticles Recent Pat. Nanotechnol. 3 2009 32 41
19. J. Kim, I. Hwang, D. Britain, T.D. Chung, Y. Sun, and D.-H. Kim Microfluidic approaches for gene delivery and gene therapy Lab Chip 11 2011 3941 3948 10.1039/c1lc20766k
20. J. Clement, K. Kiefer, A. Kimpfler, P. Garidel, and R. Peschka-Süss Large-scale production of lipoplexes with long shelf-life Eur. J. Pharm. Biopharm. 59 2005 35 43 10.1016/j.ejpb.2004.06.001
21. T.A. Balbino, A.R. Azzoni, and L.G. de La Torre Microfluidic devices for continuous production of pDNA/cationic liposome complexes for gene delivery and vaccine therapy Colloids Surf., B 111C 2013 203 210 10.1016/j.colsurfb.2013.04.003
22. N. Saranya, A. Moorthi, S. Saravanan, M.P. Devi, and N. Selvamurugan Chitosan and its derivatives for gene delivery Int. J. Biol. Macromol. 48 2011 234 238 10.1016/j.ijbiomac.2010.11.013
23. W. Khan, H. Hosseinkhani, D. Ickowicz, P.-D. Hong, D.-S. Yu, and A.J. Domb Polysaccharide gene transfection agents Acta Biomater. 8 2012 4224 4232 10.1016/j.actbio.2012.09.022
24. V. Sokolova, and M. Epple Inorganic nanoparticles as carriers of nucleic acids into cells Angew. Chem. Int. Ed. Engl. 47 2008 1382 1395 10.1002/anie.200703039
25. K. Chaturvedi, K. Ganguly, A.R. Kulkarni, V.H. Kulkarni, M.N. Nadagouda, and W.E. Rudzinski Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review Expert Opin. Drug Deliv. 8 2011 1455 1468 10.1517/17425247.2011.610790
26. C. Ortiz Mellet, J.M. García Fernández, and J.M. Benito Cyclodextrin-based gene delivery systems Chem. Soc. Rev. 40 2011 1586 1608 10.1039/c0cs00019a
27. R. Laga, R. Carlisle, M. Tangney, K. Ulbrich, and L.W. Seymour Polymer coatings for delivery of nucleic acid therapeutics J. Control. Release 161 2012 537 553 10.1016/j.jconrel.2012.02.013
28. A. Elouahabi, and J. Ruysschaert Formation and intracellular trafficking of lipoplexes and polyplexes Mol. Ther. 11 2005 336 347 10.1016/j.ymthe.2004.12.006
29. V.P. Torchilin Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery Biopolymers 90 2008 604 610 10.1002/bip.20989
30. A. Bolhassani Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer Biochim. Biophys. Acta 1816 2011 232 246 10.1016/j.bbcan.2011.07.006
31. B. Ruozi, F. Forni, R. Battini, and M.A. Vandelli Cationic liposomes for gene transfection J. Drug Target. 11 2003 407 414 10.1080/10611860310001655600
32. H.-S. Zhou, D.-P. Liu, and C.-C. Liang Challenges and strategies: the immune responses in gene therapy Med. Res. Rev. 24 2004 748 761 10.1002/(ISSN)1098-1128
33. M.L. Bondi, and E.F. Craparo Solid lipid nanoparticles for applications in gene therapy: a review of the state of the art Expert Opin. Drug Deliv. 7 2010 7 18 10.1517/17425240903362410
34. H. Bunjes Lipid nanoparticles for the delivery of poorly water-soluble drugs J. Pharm. Pharmacol. 62 2010 1637 1645 10.1111/j.2042-7158.2010.01024.x
35. S.A. Wissing, O. Kayser, and R.H. Müller Solid lipid nanoparticles for parenteral drug delivery Adv. Drug Deliv. Rev. 56 2004 1257 1272 10.1016/j.addr.2003.12.002
36. P.P. Blasi, S.S. Giovagnoli, A.A. Schoubben, M.M. Ricci, and C.C. Rossi Solid lipid nanoparticles for targeted brain drug delivery Adv. Drug Deliv. Rev. 59 2007 454 477 10.1016/j.addr.2007.04.011
37. M. Muchow, P. Maincent, and R.H. Müller Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery Drug Dev. Ind. Pharm. 34 2008 1394 1405 10.1080/03639040802130061
38. K. Manjunath, J.S. Reddy, and V. Venkateswarlu Solid lipid nanoparticles as drug delivery systems Methods Find. Exp. Clin. Pharmacol. 27 2005 127 144 10.1358/mf.2005.27.2.876286
39. R.H. Müller, K. Mäder, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177
40. L.H. du Plessis, E.B. Marais, F. Mohammed, and A.F. Kotze Applications of lipid based formulation technologies in the delivery of biotechnology-based therapeutics Curr. Pharm. Biotechnol. 15 2014 659 672
41. C. Olbrich, U. Bakowsky, C.M. Lehr, R.H. Müller, and C. Kneuer Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA J. Control. Release 77 2001 345 355
42. M.B. de Jesus, A. Radaic, I.S. Zuhorn, and E. Paula Microemulsion extrusion technique: a new method to produce lipid nanoparticles J. Nanopart. Res. 15 2013 1 15
43. Y.H. Yu, E. Kim, D.E. Park, G. Shim, S. Lee, and Y.B. Kim Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA Eur. J. Pharm. Biopharm. 80 2012 268 273 10.1016/j.ejpb.2011.11.002
44. S. Patel, S. Chavhan, H. Soni, A.K. Babbar, R. Mathur, and A.K. Mishra Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route J. Drug Target. 2010 10.3109/1061186X.2010.523787
45. W. Yu, C. Liu, J. Ye, W. Zou, N. Zhang, and W. Xu Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery Nanotechnology 20 2009 215102 10.1088/0957-4484/20/21/215102
46. A. Garud, D. Singh, and N. Garud Solid lipid nanoparticles (SLN): method, characterization and applications Int. Curr. Pharm. J. 1 2012 384 393
47. K. Tabatt, M. Sameti, C. Olbrich, R.H. Müller, and C.-M. Lehr Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer Eur. J. Pharm. Biopharm. 57 2004 155 162 10.1016/j.ejpb.2003.10.015
48. V. Jenning, A.F. Thünemann, and S.H. Gohla Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids Int. J. Pharm. 199 2000 167 177
49. V. Jenning, and S. Gohla Comparison of wax and glyceride solid lipid nanoparticles (SLN) Int. J. Pharm. 196 2000 219 222
50. C. Freitas, and R.H. Müller Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase Eur. J. Pharm. Biopharm. 47 1999 125 132 10.1016/S0939-6411(98)00074-5
51. H. Bunjes, M.H.J. Koch, and K. Westesen Influence of emulsifiers on the crystallization of solid lipid nanoparticles J. Pharm. Sci. 92 2003 1509 1520 10.1002/jps.10413
52. W. Mehnert, and K. Mäder Solid lipid nanoparticles: production, characterization and applications Adv. Drug Deliv. Rev. 47 2001 165 196
53. A.A. Attama SLN, NLC, LDC: state of the art in drug and active delivery Recent Pat. Drug Deliv. Formul. 5 2011 178 187
54. C. Tros de Ilarduya, Y. Sun, and N. Düzgüneş Gene delivery by lipoplexes and polyplexes Eur. J. Pharm. Sci. 40 2010 159 170 10.1016/j.ejps.2010.03.019
55. R. Parhi, and P. Suresh Preparation and characterization of solid lipid nanoparticles - a review Curr. Drug Discov. Technol. 9 2012 2 16
56. F. Corrias, and F. Lai New methods for lipid nanoparticles preparation Recent Pat. Drug Deliv. Formul. 5 2011 201 213
57. E.B. Souto, P. Severino, M.H.A. Santana, and S.C. Pinho Solid lipid nanoparticles: classical methods of lab production Quim. Nova 34 2011 1762 1769
58. A. Radomska-Soukharev Stability of lipid excipients in solid lipid nanoparticles Adv. Drug Deliv. Rev. 59 2007 411 418 10.1016/j.addr.2007.04.004
59. M.R. Gasco, Method for producing solid lipid microspheres having a narrow size distribution, 5250236, 1993.
60. R. Muller, J. Lucks, Arzneistoffträger Aus Festen Lipid Teilchen - Feste Lipid Nanosphären (SLN), EP 0605497, 1996
61. Z. Jiang, C. Sun, Z. Yin, F. Zhou, L. Ge, and X. Liu Comparison of two kinds of nanomedicine for targeted gene therapy: premodified or postmodified gene delivery systems Int. J. Nanomedicine 7 2012 2019 2031 10.2147/IJN.S30928
62. R.H. Müller, R. Shegokar, and C.M. Keck 20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications Curr. Drug Discov. Technol. 8 2011 207 227
63. K. Tabatt, C. Kneuer, M. Sameti, C. Olbrich, R.H. Müller, and C.-M. Lehr Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes J. Control. Release 97 2004 321 332 10.1016/j.jconrel.2004.02.029
64. A. Dingler, and S. Gohla Production of solid lipid nanoparticles (SLN): scaling up feasibilities J. Microencapsul. 19 2002 11 16 10.1080/02652040010018056
65. L.S. Battaglia, R. Cavalli, M. Trotta, Method for the preparation of solid lipid micro and nanoparticles, WO2008149215A2, 2008.
66. Zhang, Yun, Shen, Chen, Yao, and Chen Formation of solid lipid nanoparticles in a microchannel system with a cross-shaped junction Chem. Eng. Sci. 63 2008 5600 5605 10.1016/j.ces.2008.08.005
67. T.A. Balbino, N.T. Aoki, A.A.M. Gasperini, C.L.P. Oliveira, A.R. Azzoni, and L.P. Cavalcanti Continuous flow production of cationic liposomes at high lipid concentration in microfluidic devices for gene delivery applications Chem. Eng. J. 226 2013 423 433 10.1016/j.cej.2013.04.053
68. Y.H. Bae, and K. Park Targeted drug delivery to tumors: myths, reality and possibility J. Control. Release 153 2011 198 205 10.1016/j.jconrel.2011.06.001
69. A. del Pozo-Rodríguez, D. Delgado, M.A. Solinís, A.R. Gascón, and J.L. Pedraz Solid lipid nanoparticles: formulation factors affecting cell transfection capacity Int. J. Pharm. 339 2007 261 268 10.1016/j.ijpharm.2007.03.015
70. H.R. Kim, I.K. Kim, K.H. Bae, S.H. Lee, Y. Lee, and T.G. Park Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA Mol. Pharm. 5 2008 622 631 10.1021/mp8000233
71. C. Carrillo, N. Sánchez-Hernández, E. García-Montoya, P. Pérez-Lozano, J.M. Suñé-Negre, and J.R. Ticó DNA delivery via cationic solid lipid nanoparticles (SLNs) Eur. J. Pharm. Sci. 49 2013 157 165 10.1016/j.ejps.2013.02.011
72. K. Jores, W. Mehnert, M. Drechsler, H. Bunjes, C. Johann, and K. Mäder Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy J. Control. Release 95 2004 217 227 10.1016/j.jconrel.2003.11.012
73. M.B. de Jesus, A. Radaic, W.L.J. Hinrichs, C.V. Ferreira, E. de Paula, and D. Hoekstra Inclusion of the helper lipid dioleoyl-phosphatidylethanolamine in solid lipid nanoparticles inhibits their transfection efficiency J. Biomed. Nanotechnol. 10 2014 355 365 10.1166/jbn.2014.1804
74. W. Yu, C. Liu, Y. Liu, N. Zhang, and W. Xu Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages Pharm. Res. 27 2010 1584 1596 10.1007/s11095-010-0149-z
75. E. Vighi, B. Ruozi, M. Montanari, R. Battini, and E. Leo pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles Int. J. Pharm. 389 2010 254 261 10.1016/j.ijpharm.2010.01.030
76. G. Montana, M.L. Bondi, R. Carrotta, P. Picone, E.F. Craparo, and P.L. San Biagio Employment of cationic solid-lipid nanoparticles as RNA carriers Bioconjug. Chem. 18 2007 302 308 10.1021/bc0601166
77. E.B. Souto, A.J. Almeida, and R.H. Müller Lipid nanoparticles (SLN, NLC) for cutaneous drug delivery: structure, protection and skin effects J. Biomed. Nanotechnol. 3 2007 317 331 10.1166/jbn.2007.049
78. E.E. Vighi, E.E. Leot, M.M. Montanari, A.A. Mucci, M.M. Hanuskova, and V.V. Iannuccelli Structural investigation and intracellular trafficking of a novel multicomposite cationic solid lipid nanoparticle platform as a pDNA carrier Ther. Deliv. 2 2011 1419 1435 10.4155/tde.11.118
79. V. Jenning, K. Mäder, and S.H. Gohla Solid lipid nanoparticles (SLN) based on binary mixtures of liquid and solid lipids: a (1)H-NMR study Int. J. Pharm. 205 2000 15 21
80. M. Garcia-Fuentes, M.J. Alonso, and D. Torres Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures J. Colloid Interface Sci. 285 2005 590 598 10.1016/j.jcis.2004.10.012
81. J. Pietkiewicz, M. Sznitowska, and M. Placzek The expulsion of lipophilic drugs from the cores of solid lipid microspheres in diluted suspensions and in concentrates Int. J. Pharm. 310 2006 64 71 10.1016/j.ijpharm.2005.11.038
82. P.P. Karmali, and A. Chaudhuri Cationic liposomes as non-viral carriers of gene medicines: resolved issues, open questions, and future promises Med. Res. Rev. 27 2007 696 722 10.1002/med.20090
83. L. Wasungu, and D. Hoekstra Cationic lipids, lipoplexes and intracellular delivery of genes J. Control. Release 116 2006 255 264 10.1016/j.jconrel.2006.06.024
84. C.H. Spink, and J.B. Chaires Thermodynamics of the binding of a cationic lipid to DNA J. Am. Chem. Soc. 119 1997 10920 10928
85. R. Bruinsma Electrostatics of DNA-cationic lipid complexes: isoelectric instability Eur. Phys. J. E Soft Matter 4 1998 75 88
86. D. Harries, S. May, W.M. Gelbart, and A. Ben-Shaul Structure, stability, and thermodynamics of lamellar DNA-lipid complexes Biophys. J. 75 1998 159 173 10.1016/S0006-3495(98)77503-4
87. N.J. Zuidam, D. Hirsch-Lerner, S. Margulies, and Y. Barenholz Lamellarity of cationic liposomes and mode of preparation of lipoplexes affect transfection efficiency Biochim. Biophys. Acta 1419 1999 207 220
88. M.T. Kennedy, E.V. Pozharski, V.A. Rakhmanova, and R.C. Macdonald Factors governing the assembly of cationic phospholipid-DNA complexes Biophys. J. 78 2000 1620 1633 10.1016/S0006-3495(00)76714-2
89. P.C.A. Barreleiro, G. Olofsson, and P. Alexandridis Interaction of DNA with cationic vesicles: a calorimetric study J. Phys. Chem. B 104 2000 7795 7802 10.1021/jp000636c
90. K. Wagner, D. Harries, S. May, V. Kahl, J.O. Rädler, and A. Ben-Shaul Direct evidence for counterion release upon cationic lipid-DNA condensation Langmuir 16 2000 303 306 10.1016/S0006-3495(00)76720-8
91. D. Matulis, I. Rouzina, and V.A. Bloomfield Thermodynamics of cationic lipid binding to DNA and DNA condensation: roles of electrostatics and hydrophobicity J. Am. Chem. Soc. 124 2002 7331 7342
92. S.J. Eastman, C. Siegel, J. Tousignant, A.E. Smith, S.H. Cheng, and R.K. Scheule Biophysical characterization of cationic lipid: DNA complexes Biochim. Biophys. Acta 1325 1997 41 62 10.1016/S0005-2736(96)00242-8
93. E. Pozharski, and R.C. Macdonald Lipoplex thermodynamics: determination of DNA-cationic lipoid interaction energies Biophys. J. 85 2003 3969 3978 10.1016/S0006-3495(03)74811-5
94. K. Shirahama, K. Takashima, and N. Takisawa Interaction between dodecyltrimethylammonium chloride and DNA Bull. Chem. Soc. Jpn 60 1987 43 47
95. D. Hirsch-Lerner, and Y. Barenholz Hydration of lipoplexes commonly used in gene delivery: follow-up by laurdan fluorescence changes and quantification by differential scanning calorimetry Biochim. Biophys. Acta 1461 1999 47 57
96. T. Lazaridis Hydrophobic Effect 2013 John Wiley & Sons, Ltd. 10.1021/ar010058y
97. V. Oberle, U. Bakowsky, I.S. Zuhorn, and D. Hoekstra Lipoplex formation under equilibrium conditions reveals a three-step mechanism Biophys. J. 79 2000 1447 1454 10.1016/S0006-3495(00)76396-X
98. B. Ma, S. Zhang, H. Jiang, B. Zhao, and H. Lv Lipoplex morphologies and their influences on transfection efficiency in gene delivery J. Control. Release 123 2007 184 194 10.1016/j.jconrel.2007.08.022
99. C.S. Braun, G.S. Jas, S. Choosakoonkriang, and G.S. Koe The structure of DNA within cationic lipid/DNA complexes Biophys. J. 84 2003 1114 1123
100. I.S. Kikuchi, and A.M. Carmona-Ribeiro Interactions between DNA and synthetic cationic liposomes J. Phys. Chem. B 104 2000 2829 2835
101. V. Pector, J. Backmann, D. Maes, M. Vandenbranden, and J.M. Ruysschaert Biophysical and structural properties of DNA.diC(14)-amidine complexes. Influence of the DNA/lipid ratio J. Biol. Chem. 275 2000 29533 29538 10.1074/jbc.M909996199
102. H. Gershon, R. Ghirlando, S.B. Guttman, and A. Minsky Mode of formation and structural features of DNA-cationic liposome complexes used for transfection Biochemistry 32 1993 7143 7151
103. B. Sternberg, F.L. Sorgi, and L. Huang New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy FEBS Lett. 356 1994 361 366
104. D.D. Lasic, H. Strey, M.C.A. Stuart, R. Podgornik, and P.M. Frederik The structure of DNA-liposome complexes J. Am. Chem. Soc. 119 1997 832 833 10.1021/ja962713g
105. J. Smisterová, A. Wagenaar, M.C. Stuart, E. Polushkin, G. ten Brinke, and R. Hulst Molecular shape of the cationic lipid controls the structure of cationic lipid/dioleylphosphatidylethanolamine-DNA complexes and the efficiency of gene delivery J. Biol. Chem. 276 2001 47615 47622 10.1074/jbc.M106199200
106. J.O. Rädler, I. Koltover, T. Salditt, and C.R. Safinya Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes Science 275 1997 810 814
107. P.C.A. Barreleiro, R.P. May, and B.R. Lindman Mechanism of formation of DNA-cationic vesicle complexes Faraday Discuss. 122 2002 191 201 10.1039/b200796g
108. I. Koltover, T. Salditt, J.O. Rädler, and C.R. Safinya An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery Science 281 1998 78 81
109. V.A. Rakhmanova, T.J. McIntosh, and R.C. Macdonald Effects of dioleoylphosphatidylethanolamine on the activity and structure of O-alkyl phosphatidylcholine-DNA transfection complexes Cell. Mol. Biol. Lett. 5 2000 51 66
110. C.R. Safinya Structures of lipid-DNA complexes: supramolecular assembly and gene delivery Curr. Opin. Struct. Biol. 11 2001 440 448 10.1016/S0959-440X(00)00230-X
111. V. Rullaud, M. Siragusa, A. Cumbo, D. Gygax, and P. Shahgaldian DNA surface coating of calixarene-based nanoparticles: a sequence-dependent binding mechanism Chem. Commun. 48 2012 12186 12188 10.1039/c2cc36859e
112. K. Helttunen, and P. Shahgaldian Self-assembly of amphiphilic calixarenes and resorcinarenes in water New J. Chem. 34 2010 2704 2714 10.1039/c0nj00123f
113. J. Ye, A. Wang, C. Liu, Z. Chen, and N. Zhang Anionic solid lipid nanoparticles supported on protamine/DNA complexes Nanotechnology 19 2008 285708 10.1088/0957-4484/19/28/285708
114. S. Doktorovova, R. Shegokar, E. Rakovsky, E. Gonzalez-Mira, C.M. Lopes, and A.M. Silva Cationic solid lipid nanoparticles (cSLN): structure, stability and DNA binding capacity correlation studies Int. J. Pharm. 420 2011 341 349 10.1016/j.ijpharm.2011.08.042
115. R. Asasutjarit, S.-I. Lorenzen, S. Sirivichayakul, K. Ruxrungtham, U. Ruktanonchai, and G.C. Ritthidej Effect of solid lipid nanoparticles formulation compositions on their size, zeta potential and potential for in vitro pHIS-HIV-hugag transfection Pharm. Res. 24 2007 1098 1107 10.1007/s11095-007-9234-3
116. B. Moghaddam, S.E. McNeil, Q. Zheng, A.R. Mohammed, and Y. Perrie Exploring the correlation between lipid packaging in lipoplexes and their transfection efficacy Pharmaceutics 3 2011 848 864 10.3390/pharmaceutics3040848
117. R.F. Minchin, and S. Yang Endosomal disruptors in non-viral gene delivery Expert Opin. Drug Deliv. 7 2010 331 339 10.1517/17425240903512931
118. A.K. Varkouhi, M. Scholte, G. Storm, and H.J. Haisma Endosomal escape pathways for delivery of biologicals J. Control. Release 151 2011 220 228 10.1016/j.jconrel.2010.11.004
119. W. Liang, and J.K.W. Lam Endosomal escape pathways for non-viral nucleic acid delivery systems Intechopen.com 10.5772/46006 2012 InTech
120. Z.U. Rehman, D. Hoekstra, and I.S. Zuhorn On the mechanism of polyplex- and lipoplex-mediated delivery of nucleic acids: real-time visualization of transient membrane destabilization without endosomal lysis ACS Nano 2013 10.1021/nn3049494
121. J.-P. Behr The proton sponge: a trick to enter cells the viruses did not exploit Chimia 51 1997 1 2
122. R.V. Benjaminsen, M.A. Mattebjerg, J.R. Henriksen, S.M. Moghimi, and T.L. Andresen The possible "proton sponge" effect of polyethylenimine (PEI) does not include change in lysosomal pH Mol. Ther. 21 2013 149 157 10.1038/mt.2012.185
123. P. Pinnaduwage, L. Schmitt, and L. Huang Use of a quaternary ammonium detergent in liposome mediated DNA transfection of mouse L-cells Biochim. Biophys. Acta 985 1989 33 37
124. H. Farhood, N. Serbina, and L. Huang The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer Biochim. Biophys. Acta 1235 1995 289 295
125. O. Zelphati, and F. Szoka Mechanism of oligonucleotide release from cationic liposomes Proc. Natl. Acad. Sci. U. S. A. 93 1996 11493 11498
126. E.R. Lee, J. Marshall, C.S. Siegel, C. Jiang, N.S. Yew, and M.R. Nichols Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung Hum. Gene Ther. 7 1996 1701 1717 10.1089/hum.1996.7.14-1701
127. K.W. Mok, and P.R. Cullis Structural and fusogenic properties of cationic liposomes in the presence of plasmid DNA Biophys. J. 73 1997 2534 2545 10.1016/S0006-3495(97)78282-1
128. I.S. Zuhorn, U. Bakowsky, E. Polushkin, W.H. Visser, M.C.A. Stuart, and J.B.F.N. Engberts Nonbilayer phase of lipoplex-membrane mixture determines endosomal escape of genetic cargo and transfection efficiency Mol. Ther. 11 2005 801 810 10.1016/j.ymthe.2004.12.018
129. I. Wrobel, and D. Collins Fusion of cationic liposomes with mammalian cells occurs after endocytosis Biochim. Biophys. Acta 1235 1995 296 304
130. I.M. Hafez, and P.R. Cullis Roles of lipid polymorphism in intracellular delivery Adv. Drug Deliv. Rev. 47 2001 139 148
131. F. Shi, L. Wasungu, A. Nomden, M.C.A. Stuart, E. Polushkin, and J.B.F.N. Engberts Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions Biochem. J. 366 2002 333 341 10.1042/BJ20020590
132. S.H. Choi, S.-E. Jin, M.-K. Lee, S.-J. Lim, J.-S. Park, and B.-G. Kim Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells Eur. J. Pharm. Biopharm. 68 2008 545 554 10.1016/j.ejpb.2007.07.011
133. C. Rudolph, U. Schillinger, A. Ortiz, K. Tabatt, C. Plank, and R.H. Müller Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo Pharm. Res. 21 2004 1662 1669
134. D. Delgado, A. del Pozo-Rodríguez, M.Á. Solinís, and A. Rodríguez-Gascón Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: the importance of the entry pathway Eur. J. Pharm. Biopharm. 79 2011 495 502 10.1016/j.ejpb.2011.06.005
135. C.C. Olbrich, and R.H.R. Müller Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures Int. J. Pharm. 180 1999 31 39 10.1016/S0378-5173(98)00404-9
136. H.-Y. Xue, and H.-L. Wong Tailoring nanostructured solid-lipid carriers for time-controlled intracellular siRNA kinetics to sustain RNAi-mediated chemosensitization Biomaterials 32 2011 2662 2672 10.1016/j.biomaterials.2010.12.029
137. A. del Pozo-Rodríguez, D. Delgado, M.Á. Solinís, J.L. Pedraz, E. Echevarría, and J.M. Rodríguez Solid lipid nanoparticles as potential tools for gene therapy: in vivo protein expression after intravenous administration Int. J. Pharm. 385 2010 157 162 10.1016/j.ijpharm.2009.10.020
138. A.K.K. Leung, I.M. Hafez, S. Baoukina, N.M. Belliveau, I.V. Zhigaltsev, and E. Afshinmanesh Lipid nanoparticles containing siRNA synthesized by microfluidic mixing exhibit an electron-dense nanostructured core J. Phys. Chem. C Nanomater. Interfaces 116 2012 18440 18450 10.1021/jp303267y
139. H. Bunjes, M. Drechsler, M.H. Koch, and K. Westesen Incorporation of the model drug ubidecarenone into solid lipid nanoparticles Pharm. Res. 18 2001 287 293
140. M.E. Hayes, D.C. Drummond, K. Hong, J.W. Park, J.D. Marks, and D.B. Kirpotin Assembly of nucleic acid-lipid nanoparticles from aqueous-organic monophases Biochim. Biophys. Acta 1758 2006 429 442 10.1016/j.bbamem.2006.03.020
141. P. Severino, S.C. Pinho, E.B. Souto, and M.H.A. Santana Polymorphism, crystallinity and hydrophilic-lipophilic balance of stearic acid and stearic acid-capric/caprylic triglyceride matrices for production of stable nanoparticles Colloids Surf., B 86 2011 125 130 10.1016/j.colsurfb.2011.03.029
142. Y.-C. Kuo, and C.-C. Wang Electrophoresis of human brain microvascular endothelial cells with uptake of cationic solid lipid nanoparticles: effect of surfactant composition Colloids Surf., B 76 2010 286 291 10.1016/j.colsurfb.2009.11.006
143. W.C. Griffin Classification of surface-active agents by "HLB" J. Soc. Cosmet. Chem. 1 1949 311 326
144. B. Heurtault, P. Saulnier, B. Pech, J.-E. Proust, and J.-P. Benoit Physico-chemical stability of colloidal lipid particles Biomaterials 24 2003 4283 4300 10.1016/S0142-9612(03)00331-4
145. M.R. Gasco Lipid nanoparticles: perspectives and challenges Adv. Drug Deliv. Rev. 59 2007 377 378 10.1016/j.addr.2007.05.004
146. Z. Liu, Z. Zhong, G. Peng, S. Wang, X. Du, and D. Yan Folate receptor mediated intracellular gene delivery using the charge changing solid lipid nanoparticles Drug Deliv. 16 2009 341 347 10.1080/10717540903047387
147. N. Seetapan, P. Bejrapha, W. Srinuanchai, and U.R. Ruktanonchai Rheological and morphological characterizations on physical stability of gamma-oryzanol-loaded solid lipid nanoparticles (SLNs) Micron 41 2010 51 58 10.1016/j.micron.2009.08.003
148. E. Vighi, B. Ruozi, M. Montanari, R. Battini, and E. Leo Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid Eur. J. Pharm. Biopharm. 67 2007 320 328 10.1016/j.ejpb.2007.02.006
149. W. Abdelwahed, G. Degobert, S. Stainmesse, and H. Fessi Freeze-drying of nanoparticles: formulation, process and storage considerations Adv. Drug Deliv. Rev. 58 2006 1688 1713 10.1016/j.addr.2006.09.017
150. A. del Pozo-Rodríguez, M.A. Solinís, A.R. Gascón, and J.L. Pedraz Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy Eur. J. Pharm. Biopharm. 71 2009 181 189 10.1016/j.ejpb.2008.09.015
151. S.W. Poxon, and J.A. Hughes The effect of lyophilization on plasmid DNA activity Pharm. Dev. Technol. 5 2000 115 122 10.1081/PDT-100100526
152. H. Heiati, R. Tawashi, and N.C. Phillips Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization J. Microencapsul. 15 1998 173 184 10.3109/02652049809006847
153. P. Chollet, M.C. Favrot, A. Hurbin, and J.-L. Coll Side-effects of a systemic injection of linear polyethylenimine-DNA complexes J. Gene Med. 4 2002 84 91 10.1002/jgm.237